![]() |
市場調查報告書
商品編碼
1675078
微孔盤市場 - 成長、未來展望、競爭分析,2025 年至 2033 年Microplates Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033 |
微孔盤市場規模預計將從 2024 年的 9.9351 億美元成長到 2033 年的 14.88 億美元,預測期間(2025-2033 年)的複合年成長率為 4.2%。在過去的幾十年裡,微孔盤技術在生物技術研究中得到了越來越廣泛的應用。研究人員認為該儀器在維持高效、準確的資料結果以及整體研究表現方面發揮著至關重要的作用。多年來,分析測試和測定的性質發生了顯著變化,當前的市場趨勢是盡量減少藥物篩檢的數量。微孔盤設計的發展直接源自於這個因素。為了滿足研究人員不斷變化的需求,需要大量具有不同類型、顏色、孔設計和材質等特徵的微孔盤。許多製造商進行的計劃的目標之一是減少研究所需的試劑和化學品的數量,同時保持研究過程和結果的品質水平不變。屬於微孔盤和微孔盤設備類別的設備和微孔板設備是細胞培養過程以及其他類型研究的重要組成部分。最初,這些設備僅用於實驗室等研究環境。然而,如今它在疾病診斷中的應用正在增加,並被診斷實驗室和醫院廣泛使用。因此,它們現在不僅用於了解各種研究中的細胞反應,而且還用於藥物開發過程。因此,微孔盤已成為各種測試方法和生產過程中必不可少的組成部分。由於微孔板能夠同時分析許多不同的樣品,因此研究中對微孔盤的需求正在穩定成長。
ELISA 檢測需求不斷成長
酵素連結酵素結合免疫吸附檢測法(ELISA) 是一種識別荷爾蒙、抗體、胜肽和蛋白質的免疫檢測方法。 ELISA檢驗在生物技術醫學中用作診斷工具,透過檢測顏色變化來識別目標物質並估計其在測試樣本中的含量。這可以透過將樣品的顏色與標準進行比較來完成。使用 ELISA 的典型診斷應用包括檢測人類免疫力缺乏病毒 (HIV) 感染、懷孕測試以及檢測細胞激素、可溶性蛋白質和其他生物標記。免疫測量利用多種抗原-抗體組合,其中一種是酵素標記的(抗原或抗體),然後測量酵素的活性。
高通量篩檢中與目標驗證和流程自動化相關的高維修成本
目標驗證和流程自動化是製藥公司在開發過程的高通量篩檢階段遇到的最常見問題的兩個問題。在初步篩檢期間,研究人員必須克服的最大障礙是確定他們是否使用了正確的藥物。如果研究結束時目標識別被證明是不準確的,那麼通常會導致因微孔盤、化學物質和人工時間的損失而造成昂貴的浪費。在處理微孔盤的過程中,人為失誤(例如有用生物試劑的微小滴度損失、溢出和雜質)可能會導致錯誤的結果,並經常導致在二次篩檢階段與微量測定相關的設計通訊協定的驗證問題。人為錯誤導致有價值的生物試劑微量滴定液的流失或溢出,增加了新藥的高通量篩檢。為了減少人為錯誤而推動微孔盤處理自動化,導致在設計工具和軟體以確保平穩操作和預期結果方面損失了大量資金。這是微孔盤處理自動化以減少人為錯誤的直接結果。
技術相容性和標準化
微孔盤市場的技術相容性和標準化程度相當高。微孔盤是高通量檢測和篩檢的核心,在研究和診斷實驗室中已變得至關重要。確保與微孔盤讀數儀、清洗和自動化液體處理系統等各種實驗室設備無縫整合至關重要。不同製造商提供的各種設備都有各自的規格,這進一步加劇了這項挑戰。微孔盤尺寸、孔深和幾何形狀的不一致和缺乏標準化會導致嚴重的操作障礙。如果所使用的微孔盤不能普遍適用於現有的儀器設置,實驗室可能會難以實現高效可靠的處理。
新興國家加大對生物製藥產業的投資
微孔盤製造商通常將新興國家視為其產品的有利可圖的市場。這些國家擁有相當一部分目標人口。有幾個原因可能會吸引那些面臨專利到期、現有市場停滯不前和監管障礙不斷增加的大型生物製藥公司,但最重要的是提高壽命和提高盈利。這些市場對於生產微孔盤的頂級醫療設備公司的持續擴張至關重要並發揮關鍵作用。新興國家佔世界人口的很大一部分,其中很大一部分正在積極努力改善醫療體系並取得更好的治療效果。
按類型細分市場
就微孔盤類型而言,384 孔微孔盤是 2024 年最大的市場,貢獻了超過 40.1% 的收益佔有率。 384孔微孔盤的最大特點是可以進行小規模的基因轉殖實驗。這有助於最大限度地減少整個實驗過程中支付的成本,同時與其他微孔盤相比,在永生化細胞或原代細胞的轉染過程中提供高通量。
按應用細分的市場
疾病標靶發現、藥物評估和基因表徵等調查方法廣泛應用細胞培養作為基本和標準的方法。儘管該過程性質複雜,但與體內研究方法相比,它更容易獲得、成本更低、相對省時省力,並且涉及的倫理考慮更少。細胞培養可以藉助巨型生物反應器大規模進行,也可以藉助多壁板小規模進行。微孔盤在細胞培養模型中的使用越來越受歡迎,因為這些模型可以分析許多動態變量,從而改善實驗結果,同時減少實驗運行所需的時間和成本。
區域市場區隔
北美目前佔據 2024 年全球微孔盤市場的最大收益佔有率,貢獻率約為 30.1%。北美慢性病和急性病患病率的上升以及可及時診斷和治療的醫療設施的增加是推動該地區市場收益成長的主要促進因素。此外,預計該地區在整個預測期內仍將保持主導地位。推動該地區市場擴張的另一個因素是生物實驗室自動化程度的日益提高。預計預測期內亞太地區的市場將顯著成長。這是醫療保健基礎設施快速成長以及生物技術和製藥研發投資增加的結果。生物研究方法外包的擴大也是一個主要促進因素。
併購仍是領導企業部署的最重要市場策略之一
由於全球微孔盤市場知名參與者的存在,市場競爭非常激烈。報告中介紹的主要企業簡介包括康寧公司 (Corning Incorporated)、賽默飛世爾科技公司 (Thermo Fisher Scientific, Inc)、珀金埃爾默公司 (PerkinElmer, Inc)、Eppendorf AG、Porvair Sciences Limited、Berthold Technologies GmbH &Co.KG、Grel. Laborgerate GmbH &Co.KG。儘管新產品開發在過去五年中仍然是一項關鍵策略,但趨勢已經發生了顯著變化。層級公司注重綜合策略,包括併購,注重整體發展,而非以產品為導向的策略。例如,只有賽默飛世爾科技在 2020 年至 2021 年期間進行了四次以上的相關收購。 2021 年 9 月,Avantor, Inc. 宣布已簽署最終協議,收購 Antylia Scientific 的生物製程業務和相關資產(統稱為「Masterflex」)。 Antylia Scientific 是投資公司 GTCR 和 Golden Gate Capital 的投資組合公司。 2021年6月,Avantor也完成了對Ritter GmbH及其附屬公司的收購。此次收購旨在加強 Avantor 在分子診斷領域的地位。 COVID-19 對併購市場產生了重大影響,但層級公司正專注於此策略。
The microplates market is set to reach US$ 1488 million by 2033 from US$ 993.51 million in 2024 at a compound annual growth rate (CAGR) of 4.2% during the forecast period from 2025 to 2033. Microplate technologies has been increasingly applied across variety of applications within the field of biotechnology research over the past couple of decades. Researchers are of the opinion that the equipment plays an essential part in the upkeep of productive and accurate data outcomes, as well as in the overall performance of the study. The nature of analytical tests and assays has changed significantly over the course of the years, and a trend toward volume minimization for the purpose of performing drug screening can currently be observed in the market. The design of microplates is evolving as a direct result of this factor. To meet the ever-changing needs of researchers, a significant quantity of microplates, each with its own kind, color, well design, and material, among other characteristics, is necessary. The goal of one of the many projects being pursued by manufacturers is to cut down on the quantity of reagents and chemicals needed for research while maintaining the same level of quality in both the process and the results. Devices belonging to the microplate and microplate instrumentation categories are an essential part of the cell culture process as well as other types of research. In the beginning, these devices were exclusively utilized in research settings, such as laboratories. However, currently there has been increased use in the field of disease diagnosis, which led to their presence in diagnostic laboratories as well as hospitals. As a result, microplates are used in the process of drug discovery and development, in addition to comprehending the cellular reactions in any type of research. As a result, microplates are necessary components in a variety of testing methods and production processes. The need for microplates in research settings is steadily increasing as a direct result of their capacity to perform simultaneous analysis on a number of different samples.
Increasing Demand for ELISA Testing
The Enzyme-Linked Immunosorbent Assay, more often known as ELISA, is a type of immunoassay that may recognize hormones, antibodies, peptides, and proteins. The ELISA assay has applications in biotechnology medicine as a diagnostic tool that detects a color change to identify a target substance and estimates its quantity in the test sample. This can be done by comparing the color of the sample to a standard. Infection with the Human Immunodeficiency Virus (HIV), tests to determine whether or not a woman is pregnant, and the detection of cytokines, soluble proteins, and other biomarkers are typical diagnostic applications of ELISA. The immunoassay makes use of a wide variety of antigen-antibody combinations, one of which is enzyme-labeled (either the antigen or the antibody), and measures the activity of the enzyme.
High Maintenance Cost Associated with Target Validation and Process Automation Pertaining to High Throughput Screening
Target validation and process automation are the two issues that pharmaceutical companies run into most frequently during the high throughput screening stages of the development process. During the main screening, the greatest obstacle that researchers must overcome is determining whether or not they are working with the appropriate drug. If the target identification is revealed to be incorrect at the conclusion of the test, this frequently leads to a wasteful endeavor that costs money due to the loss of microplates, chemicals, and working hours. Accidents caused by humans, such as the loss of micro titers of useful biological reagents, spilling, and the addition of impurities while handling microplates, have led to erroneous results, which have frequently led to validation issues of designed protocols pertaining to micro assays during the secondary screening stage. Human errors, such as the loss of micro titers of useful biological reagents, spilling, and the addition of high throughput screening of novel drugs, the automation of microplate handling to reduce human error is resulting in the loss of huge funds to design tools and software to ensure smooth operations and desired results. This is a direct result of the automation of microplate handling to reduce human error.
Technological Compatibility and Standardization
Technological Compatibility and Standardization in the microplate market is a substantial one. Microplates are central to high-throughput assays and screenings, making them integral in research and diagnostic laboratories. Ensuring they seamlessly integrate with various laboratory instruments, such as microplate readers, washers, and automated liquid handling systems, is crucial. The diversity of equipment from different manufacturers each with their unique specifications, exacerbates the challenge. Inconsistencies or lack of standardization in microplate dimensions, well depth, and shape can lead to significant operational hurdles. Labs may encounter difficulties in achieving efficient and reliable processing if the microplates used are not universally compatible with their existing equipment setup.
Increasing Investment in The Biopharmaceutical Industry in Emerging Economies
Manufacturers of microplates often view emerging economies as lucrative destinations to sell their products. These nations are home to significant portions of the target population. The key biopharmaceutical players who are experiencing patent expirations, stagnation of established markets, and rising regulatory hurdles can be attracted to your company for a number of reasons, but the most important ones are improving lifespan and expanding profitability. These markets are extremely important to the continued expansion of top medical device firms that manufacture microplates, and they play an important part in that expansion. Developing countries are home to a sizeable portion of the world's population, and a large fraction of that population is actively working to improve their healthcare systems and achieve better treatment outcomes.
Market Segmentation By Type
With respect to the type of microplates, the 384-well microplates were the largest market in 2024 contributing to over 40.1% of the revenue share. Their capacity to carry out miniature gene transfer experiments is the defining characteristic that contributes most significantly to their preeminence. This assists in minimizing the cost that is paid throughout the procedures of the experiment, and at the same time, it gives a high throughput during the transfection of immortalized and primary cells in contrast to other microplates.
Market Segmentation By Application
Research techniques such as the discovery of disease targets, drug assessment, and gene characterization extensively apply cell culture as a fundamental and standard methodology. The nature of this process is complex; nonetheless, it is significantly easier to access, less expensive, and comparatively time and labor efficient than in vivo research approaches, and it also has fewer ethical considerations. Cell culture can be carried out at a large scale with the assistance of huge bioreactors, or it can be carried out at a small size with the assistance of multiwall plates. The use of microplates in cell culture models is gaining popularity because these models enable the analysis of a multitude of dynamic variables, which in turn enables increased experiment output while simultaneously lowering the amount of time and money required for the experiment.
Market Segmentation By Geography
North America currently held the largest revenue share in the global microplates market in 2024 by contributing to about 30.1%. The rising prevalence of chronic and acute disease conditions in North America, as well as the widespread availability of healthcare facilities for prompt diagnosis and treatment are the key drivers boosting the market revenues in this region. This region is also expected to maintain its leading position throughout the duration of the forecast period. Another factor contributing to the expansion of the market in this region is the increasing trend of automation in biolaboratories. It is anticipated that the Asia Pacific region would experience significant market expansion over the course of the projected period. This occurs as a result of the rapid growth of the infrastructure of healthcare and the increased investments in research and development of biotechnology and medicines. The growing outsourcing of biotechnology contract research processes is also among the key drivers.
M&A Remains One of the Most Significant Market Strategies Deployed by Top Companies
The global microplates market is characterized by some notable players and hence, the market is quite fierce in terms of competition. Key players profiled in the report include Corning Incorporated, Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Eppendorf AG, Porvair Sciences Limited, Berthold Technologies GmbH & Co. KG, Greiner Bio One International GmbH, Avantor, Inc., Becton, Dickison and Company, QIAGEN N.V., SPL Life Sciences, Hirschmann Laborgerate GmbH & Co. KG, among others. Though new product development has remained the key strategy in the previous 5 years, the trend has changed significantly. Tier 1 companies are focusing on umbrella strategies which include mergers and acquisitions focused on holistic development rather than product-oriented strategies. For example, only Thermo Fischer has performed over 4 relevant acquisitions during the period of 2020 to 2021. In Sep 2021 Avantor, Inc announced that it has entered into a definitive agreement to acquire the Masterflex bioprocessing business and related assets (collectively "Masterflex") of Antylia Scientific, a privately held, portfolio company of investment firms GTCR and Golden Gate Capital. In June 2021, Avantor also completed the acquisition of Ritter GmbH and its AffiliatesThe acquisition aims at enhancing the company's position in the field of molecular diagnostics as a whole. Though COVID-19 has impacted the market largely with respect to mergers and acquisitions, Tier 1 companies have focused on this strategy.
Historical & Forecast Period
This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Microplates market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Microplates market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.